A. Papi (Ferrara, Italy), F. Polverino (Tucson, United States of America)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Diagnostic utility of serum periostin for house dust mite sublingual immunotherapy response in allergic rhinitis
M. Hoshino (Atami, Japan), K. Akitsu (Atami, Japan), K. Kubota (Atami, Japan), J. Ohtawa (Atami, Japan)
|   |
Dupilumab sustains long-term OCS reduction in OCS-dependent asthma patients
L. Sher (Rolling Hills Estates, United States of America), M. Wechsler (Denver, United States of America), K. Rabe (Grosshansdorf & Kiel, Germany), J. Maspero (Buenos Aires, Argentina), N. Daizadeh (Cambridge, United States of America), X. Mao (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), L. Mannent (Chilly-Mazarin, France), E. Laws (Bridgewater, United States of America), M. Ruddy (Tarrytown, United States of America), N. Pandit-Abid (Bridgewater, United States of America), D. Lederer (Tarrytown, United States of America), M. Hardin (Cambridge, United States of America)
| |
SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials
J. Mullol (Barcelona, Catalonia, Spain), G. Canonica (Milan, Italy), M. Wagenmann (Düsseldorf, Germany), A. Coste (Creteil, France), P. Hellings (Leuven, Belgium), S. Nash (Tarrytown, NY, United States of America), S. Kamat (Tarrytown, NY, United States of America), U. Mujumdar (Cambridge, MA, United States of America), J. Msihid (Chilly-Mazarin, France), A. Khan (Chilly-Mazarin, France), S. Siddiqui (Tarrytown, NY, United States of America), J. Jacob-Nara (Cambridge, MA, United States of America), Y. Deniz (Tarrytown, NY, United States of America), P. Rowe (Bridgewater, NJ, United States of America)
| |
Efficacy of dupilumab in patients with oral corticosteroid (OCS)-dependent, severe asthma with and without an allergic phenotype: phase 3 LIBERTY ASTHMA VENTURE
G. Brusselle (Ghent, Belgium), A. Papi (Ferrara, Italy), B. Chipps (Sacramento, CA, United States of America), J. Msihid (Chilly-Mazarin, France), J. Jacob-Nara (Bridgewater, NJ, United States of America), Y. Deniz (Tarrytown, NY, United States of America), P. Rowe (Bridgewater, NJ, United States of America), R. Gall (Tarrytown, NY, United States of America), B. Ortiz (Tarrytown, NY, United States of America), M. Djandji (Cambridge, MA, United States of America), A. Radwan (Tarrytown, NY, United States of America)
| |
Evaluation of nasal response to birch allergen in ALYATEC EEC as compared to NPT
A. Gherasim (Strasbourg, France), F. Dietsch (Strasbourg, France), M. Beck (Strasbourg, France), M. Meyer (Strasbourg, France), T. Riff (Strasbourg, France), N. Domis (Strasbourg, France), F. De Blay (Strasbourg, France)
| |
Platelet aggregation status in chronic obstructive pulmonary disease associated with SARS-Cov-19
L. Todoriko (Chernivtsi, Ukraine), M. Gumeniuk (Kiyv, Ukraine), I. Semianiv (Chernivtsi, Ukraine), T. Sprynsian (Kiyv, Ukraine), O. Denisov (Kiyv, Ukraine)
| |
Severe asthma biologic treatment in the era of COVID-19 – case series
P. Nogueira Costa (Coimbra, Portugal), C. Chaves Loureiro (Coimbra, Portugal)
| |
Is asthma a risk factor for severe outcomes in COVID 19?
A. Saidani (Sfax, Tunisia), S. Maddeh (Sfax, Tunisia), N. Kallel (Sfax, Tunisia), N. Moussa (Sfax, Tunisia), R. Gargouri (Sfax, Tunisia), A. Kotti (Sfax, Tunisia), N. Bahloul (Sfax, Tunisia), W. Fki (Sfax, Tunisia), S. Kammoun (Sfax, Tunisia)
| |
Late Breaking Abstract - DCLK1 mediates thrombin-induced IL-8/CXCL8 expression in lung epithelial cells
F. Yuliani (Taipei, Taiwan), J. Chen (Taipei, Taiwan), W. Cheng (Taipei, Taiwan), H. Wen (Taipei, Taiwan), B. Chen (Taipei, Taiwan), C. Lin (Taipei, Taiwan)
| |
Late Breaking Abstract - Steroid resistance in obese asthmatic patients: a potential role of obesity-related systemic oxidative stress
M. To (Saitama, Japan), N. Honda (Saitama, Japan), I. Kano (Saitama, Japan), K. Haruki (Saitama, Japan), Y. To (Chiba, Japan)
| |
Late Breaking Abstract - Hypoxia dampens the allergen-dependent adaptive immune response and ameliorates allergic asthma in vivo
M. Hochgerner (Graz, Austria), E. Sturm (Graz, Austria), D. Schnoegl (Graz, Austria), G. Kwapiszewska (Graz, Austria), H. Olschewski (Graz, Austria), L. Marsh (Graz, Austria)
| |
Late Breaking Abstract - Delivery of anti-inflammatory and anti-oxidant synthetic mRNA to a rodent ARDS model by vibrating mesh nebulisation
S. McCarthy (Galway, Ireland), M. Angel (MA, United States of America), C. Rohde (MA, United States of America), C. Masterson (Galway, Ireland), R. Macloughlin (Galway, Ireland), J. Laffey (Galway, Ireland), D. O'Toole (Galway, Ireland)
| |
Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype
A. Saikumar Jayalatha (Groningen , Netherlands), L. Hesse (Groningen , Netherlands), M. Ketelaar (Groningen , Netherlands), M. Van Den Berge (Groningen , Netherlands), V. Gurvey (Groningen , Netherlands), G. Koppelman (Groningen , Netherlands), M. Nawijn (Groningen , Netherlands)
| |